Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1b4b4b21b425a0f495ecb47c7e27385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7a4950f9410416be9d6b5761f17698c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e34954e3f5360f0580e3956682a4d897 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c79ce30dc9d243f80835c0770c928f6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd378b9bbde48a106ec3cba7046b8eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa6108c5b32350e93420db7fc82b944 |
publicationDate |
2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9200080-B2 |
titleOfInvention |
Agonistic antibodies to TrkC receptors and uses thereof |
abstract |
There are provided herein novel monoclonal antibodies that selectively bind and/or activate TrkC receptors, pharmaceutical compositions thereof and the use thereof for treating or preventing conditions which require activation of TrkC, such as amyotrophic lateral sclerosis and other neurodegenerative conditions and motor neuron diseases. The monoclonal antibodies are useful to screen for agents that share the same binding epitope on the TrkC receptor. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020017590-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941203-B2 |
priorityDate |
2010-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |